USE OF INJECTABLE VALPROIC ACID IN STATUS EPILEPTICUS - A PILOT-STUDY

被引：64

作者：

GIROUD, M ^{[1
]}

GRAS, D ^{[1
]}

ESCOUSSE, A ^{[1
]}

DUMAS, R ^{[1
]}

VENAUD, G ^{[1
]}

机构：

[1] GEN HOSP,DEPT NEUROL,DIJON,FRANCE

来源：

DRUG INVESTIGATION | 1993年 / 5卷 / 03期

关键词：

D O I：

10.1007/BF03258440

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

As predicted in previous studies where valproic acid (Depakine(R), VPA, sodium valproate) was administered as an oral or rectal loading dose, VPA administered via injection was shown to be effective in the immediate treatment of status epilepticus (SE). This rapid efficacy is obtained simply by direct initial injection of 15 mg/kg and maintained by a 5- to 6-hour infusion at a rate of 1 mg/kg/h starting 30 minutes after the end of the bolus. With these doses, which are very close to those used traditionally with oral formulations, SE disappeared in less than 20 minutes in 19 of 23 cases. The clinical improvement was accompanied by the disappearance of critical electroencephalographic activities. The absence of impairment of concentration, and of respiratory or cardiovascular problems, and the maintenance of biological parameters, rendered the management of treatment with this VPA injectable form particularly easy.

引用

页码：154 / 159

页数：6

共 23 条

[1]

Barnes S.E., Bland D., Et al., The use of sodium valproate in a case of status epilepticus, Developmental Medicine and Child Neurology, 18, pp. 236-237, (1976)

[2]

Berkovic S.F., Andermann F., Guberma A., Hipola D., Bladin P.F., Valproate prevents the recurrence of absence status, Neurology, 3, pp. 1294-1297, (1989)

[3]

Bourgeois B.F.D., Valproate, clinical use in antiepileptic drugs, pp. 633-642, (1989)

[4]

Bourgeois B., Et al., Monotherapy with valproate in primary generalised epilepsia, Epilepsia, 28, 2, (1987)

[5]

Brodie M.J., Status epilepticus in adults, Lancet, 336, pp. 551-553, (1990)

[6]

Callaghan N., Et al., A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy, Journal of Neurology, Neurosurgery and Psychiatry, 68, pp. 639-644, (1985)

[7]

Carter Snead O., Miles M.V., Treatment of status epilepticus in children with rectal sodium valproate, Clinical and Laboratory Observation, 108, pp. 323-325, (1984)

[8]

Chadwick D.W., Valproate monotherapy in the management of generalised and partial seizures, Epilepsia, 28, 2, (1987)

[9]

Feurstein J., A long term study of monotherapy with sodium valproate in primary generalised epilepsy, British Journal of Clinical Practice, 27, pp. 17-23, (1983)

[10]

Frey H.H., Loscher W., Distribution of valproate across the interface between blood and cerebro-spinal fluid, Neuropharmacology, 17, pp. 637-642, (1978)

← 1 2 3 →